Drug Type Small molecule drug |
Synonyms Darexaban, Darexaban maleate (JAN), YM 150 + [2] |
Target |
Mechanism factor Xa inhibitors(Factor Xa inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC31H34N4O8 |
InChIKeyWHMPMUVISXATBH-BTJKTKAUSA-N |
CAS Registry365462-24-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D09817 | Darexaban Maleate | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Venous Thromboembolism | Phase 3 | US | 01 Apr 2009 | |
Venous Thromboembolism | Phase 3 | AU | 01 Apr 2009 | |
Venous Thromboembolism | Phase 3 | AT | 01 Apr 2009 | |
Venous Thromboembolism | Phase 3 | BA | 01 Apr 2009 | |
Venous Thromboembolism | Phase 3 | BR | 01 Apr 2009 | |
Venous Thromboembolism | Phase 3 | CA | 01 Apr 2009 | |
Venous Thromboembolism | Phase 3 | CO | 01 Apr 2009 | |
Venous Thromboembolism | Phase 3 | CZ | 01 Apr 2009 | |
Venous Thromboembolism | Phase 3 | DK | 01 Apr 2009 | |
Venous Thromboembolism | Phase 3 | EE | 01 Apr 2009 |
Phase 3 | - | 156 | ctfjcakhsf(uublwmwvgx) = oswukhgzgm uahenupziv (pkhyzcsihy ) View more | - | 01 Sep 2012 | ||
(Mechanical prophylaxis) | ctfjcakhsf(uublwmwvgx) = uztjwrogzf uahenupziv (pkhyzcsihy ) View more | ||||||
Not Applicable | 1,017 | uihsutwpyk(tektkjrmpt) = tkplcumifv ercnnnhnhm (ssovnabzus ) | - | 01 Apr 2010 | |||
uihsutwpyk(tektkjrmpt) = hzsvyueskc ercnnnhnhm (ssovnabzus ) |